Sildenafil
NDC 27241-175, Sildenafil, powder, for suspension, from Ajanta Pharma USA Inc..
- Product NDC
- 27241-175
- Status
- Listed
- Labeler
- Ajanta Pharma USA Inc.
- Dosage form
- POWDER, FOR SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA212883
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/27241-175 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SILDENAFIL CITRATE10 mg/mL
Pharmacologic classes
Phosphodiesterase 5 Inhibitor [EPC]; Phosphodiesterase 5 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 27241-175-29 | 27241017529 | 1 POUCH in 1 CARTON (27241-175-29) / 1 BOTTLE in 1 POUCH / 112 mL in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/283790ed-2acb-4714-a0af-b348bb642785NADAC price for package 27241017529
GET /v1/drugs/nadac/27241017529
Use it
Look up 27241-175 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/27241-175 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 27241-175. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.